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Background: Sex speciﬁc temporal trends in the incidence and prevalence of hospitalization for heart failure (HF),
particularly in conjunction with reduced and preserved left ventricular ejection fraction (EF) remain unclear,
especially in Asian general populations.
Methods:We conducted a community based HF registration study over a 10 year period in an aging cohort of the
Japanese general population.
Results: A total of 2598 cases of hospitalized HF were registered during the survey period. Of these 1413 cases
(55%) were initial admissions for HF (incident case). The study period was divided into ﬁve 2-year terms (T1,
2003–2004; T2, 2005–2006; T3, 2007–2008; T4, 2009–2010; T5, 2011–2012), and data were compared among
the terms. Age adjusted incidence of HF (per 105 person-year) remained stable inmen, but decreased signiﬁcant-
ly by 25% in women (from 104 at T1 to 79 at T5; p for trend b0.05). Among incident cases who underwent
echocardiography (≈90%), the proportion of HF with preserved EF increased in men (from 32% at T1 to 43% at
T5; p for trend b0.05), and was relatively high and remained stable throughout the study period in women
(from 52% at T1 to 58% at T5; p for trend; NS).
Conclusion: Although the incidence of HF has declined especially in women between 2003 and 2012 in the study
population, the proportion of HF with preserved EF has increased over time. These trends suggest a future
prevalence of HF with preserved EF rather than HF with reduced EF in aging Asian populations.
© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
It has been recognized that heart failure (HF) is a growing public
health problem in industrialized nations with aging populations [1–3].
Although many reports have described the incidence and hospitaliza-
tion rates for HF in various districts and countries mainly in North
America and Europe [4–9], population based studies about recent
temporal trends in HF incidence in terms of subtypes with reduced
ejection fraction (HF reduced-EF) or preserved ejection fraction (HF
preserved-EF) are very limited, especially in Asian countries.
Among elderly population, the proportion of HFpreserved-EFwithin
overall HF is higher in women than in men [10–14], whereas HFlogy, Department of Internal
oka, Iwate 020-8505, Japan.
mura).
land Ltd. This is an open access articlreduced-EF is more common in men than in women. There may be
some differences between the genders in terms of the etiology and
prevalence of structural heart disease underlying HF. In fact, the
Framingham heart study has reported a signiﬁcantly lower prevalence
of coronary artery disease in women compared to men among patients
with HF [12]. Moreover, other underlying risk factors for HF such as
valvular heart disease, hypertension and diabetes are more common in
women than in men [12]. It may therefore be important to elucidate sex
speciﬁc differences in the incidence and prevalence of HF according to
ejection fraction and how these differences may have changed over time.
However, few sex speciﬁc population based studies have examined
temporal changes in the incidence (initial admission for HF) and
prevalence (initial or recurrent admission for HF) of hospitalized HF in
relation to subtypes of left ventricular dysfunction. Owan et al. have
studied the number of admissions for HF in Mayo clinic hospitals from
1986 to 2002, and described an increase in the prevalence of HFe under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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this previous study did not indicate whether temporal trends were sim-
ilar in both sexes orwhether temporal trends in incidence parallel those
for prevalence. Steinberg et al. have reported that the percentage of HF
preserved-EF among voluntary based patients with HF increased gradu-
ally by approximately 5% during a 5 year study period [15]. However,
this studymay have included an inherent selection bias for HF patients,
and also did not attempt any sex speciﬁc analysis of temporal trends of
HF according to left ventricular function subtypes.
We have therefore performed a prospective population based
registration study for hospitalized HF with the speciﬁc aim of deﬁning
temporal trends in the incidence of HF in the northern part of Iwate,
Japan, over a 10 year period. We also investigated whether changes in
the incidence and prevalence of HF preserved-EF and HF reduced-EF
differed between men and women.
2. Methods
2.1. Study population
The study area comprised the districts of Ninohe and Kuji, a rural
area situated in the northern part of Iwate prefecture, Honshu, Japan
(Fig. 1). The population of this region decreased gradually from
135,395 in 2003 to 119,597 in 2012. However, the proportion of elderly
(aged ≥65 years) increased from 26% in 2003 to 31% in 2012. The num-
ber of elderly women was 1.5 times higher than that of men. This areaFig. 1. Study area. Black zone indicates thhas a low migration rate with a relatively stable population (i.e. in
2010, 93 elderly persons moved into the area and 151 moved out).
2.2. Case registration
The study area had only six general hospitals (Ninohe, Ichinohe,
Karumai, Ibonai, Hirono, and Kuji hospitals) and no other medical
providers in the area had cardiology admission facilities. Patients with
decompensated HF were mostly admitted to the two hospitals (Ninohe
andKuji)which had fulltime attending cardiologists. The other 4 branch
hospitals were usually not equipped to perform specialized tests and
provide intensive care for overt HF. For these hospitals, part-time
cardiologists from the major two hospitals visited regularly to provide
cardiac examination such as 2-dimensional transthoracic echocardio-
graphic (TTE) andmedical advice to attending internists. Other medical
facilities including local general practitioners in the study area did not
provide care for symptomatic patients with HF on a regular basis.
Thus, the above 6 general hospitals were selected for prospective regis-
tration. In addition, the registration study was extended to include 5
teaching hospitals located in remote urban areas such as Morioka city
and Hachinohe city to capture patients who may have directly visited
medical centers located outside of the study area (Fig. 1). During the
10 year study period, the study team of cardiologists and trained re-
search nurses regularly retrieved and reviewed medical charts and/or
discharge summaries for nearly all patients admitted to the cardiology
and internal medicine wards at each of these 11 hospitals. Patientse northern part of Iwate prefecture.
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admission only.
TTE evaluation such as left ventricular ejection fraction assessment
(Simpson or Teichholz method) was performed for nearly all patients
with HF by full time attending cardiologists. However, in the branch
hospitals without attending cardiologists, left ventricular ejection frac-
tion was occasionally missing (≈10% in the incidence cohort;
Table 1). Patients with a left ventricular ejection fraction of 50% or
higher were classiﬁed as having HF preserved-EF, whereas those with
an ejection fraction of less than 50% were classiﬁed as HF reduced-EF
[16,17].
2.3. Inclusion criteria and enrolment
Decompensated HF cases were registered from January 1, 2003 to
December 31, 2012 within the study area. Inclusion criteria were
based on the Framingham HF criteria [18]. Patients were enrolled if
they had been hospitalized and fulﬁlled the following conditions:
1) were established residents of the study district, 2) were admitted
during the study period. Patients were excluded if they had been hospi-
talized: 1) to undergo planned cardiac examination and therapies,
2) with an advanced stage malignant tumor and/or preceding apparent
pneumonia, 3) within 4 weeks after onset of acute myocardial
infarction, 4) with end stage renal failure without apparent cardiac
dysfunction.
2.4. Ethics
Approval was obtained from the ethics review board of each
participating hospital and our University Ethics Committee prior to
commencement of the study.
2.5. Data analysis
The 10 year study period was divided into ﬁve 2-year terms (T1,
2003–2004; T2, 2005–2006; T3, 2007–2008; T4, 2009–2010; T5, 2011–
2012), and datawere compared accordingly among theﬁve time periods.
Crude incidence rates were calculated as the observed number of HFTable 1
Comparisons of clinical characteristics of incident and prevalent HF cohorts among terms 1 to
All terms 2003-2012 T1 2003-
Incident cohort (n = 1413)
Men
Number 632 144
Mean age ± SD (year) 75 ± 13 73 ± 12
Atrial ﬁbrillation 58% 62%
Transthoracic echocardiography 92% 92%
Age-adjusted mortality (95%CI) per 105 person-year 13 (6 -20) 12 (5 -19
Women
Number 781 152
Mean age ± SD (year) 83 ± 11 81 ± 10
Atrial ﬁbrillation 50% 44%
Transthoracic echocardiography 88% 89%
Age-adjusted mortality (95%CI) per 105 person-year 11 (4 -17) 9 (3 -15)
Prevalent cohort (n = 2598)
Men
Number 1156 235
Mean age ± SD (year) 76 ± 12 74 ± 13
Atrial ﬁbrillation 62% 60%
Transthoracic echocardiography 89% 87%
Age-adjusted mortality (95%CI) per 105 person-year 16 (8 - 24) 11 (4 -17
Women
Number 1442 256
Mean age ± SD (year) 83 ± 10 81 ± 11
Atrial ﬁbrillation 53% 45%
Transthoracic echocardiography 84% 80%
Age-adjusted mortality (95%CI) per 105 person-year 26 (16 - 36) 20 (11 -
⁎ p= among T1-T5cases divided by the area population (person-year). In addition, the
incidence rate was adjusted by the 2010 Japanese standard population.
Continuous variables are expressed as mean ± SD. Group comparisons
were based on Student's T test, one-way ANOVA or Kruskal–Wallis test,
as appropriate. The signiﬁcance of trends in several parameters among
T1 to T5 were tested by Poisson trend analysis. A signiﬁcant difference
was deﬁned as p b 0.05.
3. Results
3.1. Clinical characteristics
During the 10 year survey period, a total of 2598 cases of hospital-
ized decompensated HF were registered (men 1156, women 1442,
M:F = 1:1.2; prevalent cohort in Table 1). More than half (n = 1413)
were initial hospitalizations for HF (incident cohort in Table 1). In
both cohorts, the mean age of patients with HF increased signiﬁcantly
over time, and clinical class of HF was relatively severe with approxi-
mately 60% of cases being NYHA 3 or 4. Atrial ﬁbrillation was present
in approximately 60% ofmen and 50% of women. Echocardiographic pa-
rameters were obtained in nearly 90% of the incident cohort (men 92%;
women 88%). The performance rate of TTEwas stable across the 5 terms
in the incident cohort (Table 1). In terms of temporal trends of age
adjusted in-hospital mortality for both incident and prevalent cohorts,
no signiﬁcant changes were found during the study period (Table 1).
3.2. Incidence rate
The crude and age adjusted incidence rates (per 100,000 person-
year) are shown in Fig. 2. The temporal trend in crude incidence rate
did not change throughout the study period in either sex. Although
the age adjusted incidence rate in men was stable over time (from
110 at T1 to 88 at T5; NS), the rate in women decreased gradually
from 104 (95% CI, 84–124) in T1 to 79 (95% CI, 61–96) in T5 (p for
trend b0.05). The age speciﬁc temporal trend in incidence rates are
shown in Fig. 3. The highest rate was observed in the ≥80 years age
band in both sexes. The rate in men was stable at around 800 through-
out the study period (NS), whereas the rate in women was decreased5.
2004 T2 2005-2006 T3 2007-2008 T4 2009-2010 T5 2011-2012 p values⁎
96 131 124 137
74 ± 13 76 ± 13 76 ± 13 77 ± 12 b0.05
62% 55% 55% 59% NS
82% 94% 94% 94% NS
) 22 (13 - 31) 15 (7 - 22) 7 (2 -13) 11 (4 -17) NS
170 162 145 152
81 ± 12 83 ± 12 82 ± 11 85 ± 8 b0.01
52% 48% 52% 52% NS
81% 90% 90% 91% NS
18 (10 - 26) 12 (5 -19) 6 (1 - 11) 10 (4-16) NS
189 244 234 254
76 ± 12 76 ± 13 77 ± 11 78 ± 11 b0.05
62% 60% 63% 64% NS
80% 91% 94% 92% b0.01
) 15 (7 - 22) 21 (12 - 30) 18 (10 - 23) 16 (8 - 24) NS
299 311 273 303
83 ± 12 83 ± 11 84 ± 10 86 ± 8 b0.01
53% 48% 58% 57% b0.01
75% 86% 88% 92% b0.01
29) 38 (26 - 50) 29 (18 - 39) 21 (12 - 30) 23 (14 - 32) NS
Fig. 2. Sex speciﬁc temporal trends in crude and age adjusted incidence rates ofHF overﬁve time periods (T1, 2003–2004; T2, 2005–2006; T3, 2007–2008; T4, 2009–2010; T5, 2011–2012).
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in T5 (p for trend b0.01). For the younger age bands of 60–69 and 70–79
years, the incidence decreased gradually over time in both sexes (p for
trend b0.01: Fig. 3).
3.3. Prevalence rate
As shown in Fig. 4, the crude prevalence rate (per 100,000 person-
year) increased signiﬁcantly from 184 (95% CI, 157–210) in T1 to 224
(95% CI, 195–256) in T5 in men (p for trend b0.05), and from 181
(95% CI, 155–207) in T1 to 238 (95% CI, 208–268) in T5 in women (p
for trend b0.05). However, the temporal trend for age adjusted preva-
lence rate did not change in either sex. The age speciﬁc trend for preva-
lence rate is demonstrated in Fig. 5. In both sexes, the rate for the
highest age band (≥80 years) was stable throughout the study period,
while in the younger age bands the rate decreased gradually over time
in both sexes.
3.4. Left ventricular function subtype
In cases who underwent 2-dimensional TTE (≅90% of the incident
cohort), actual case number per term for HF preserved-EF in men
tended to increase over time (from 42 in Term 1 to 55 in Term 5),
while in women the case number increased gradually and overtook
the rate for HF reduced-EF in Term 5 (HF preserved-EF, n = 79 versus
HF reduced-EF, n = 58). The percentage of HF preserved-EF in men
increased signiﬁcantly from 32% in T1 to 43% in T5 (p for trend b0.05;
Fig. 6), while inwomen, the proportion of HF preserved-EFwas relatively
high at more than 50% and this remained stable throughout the study
period (from 52% at T1 to 58%. at T5; p for trend NS): Fig. 6.Fig. 3. Sex and age speciﬁc incidence rates of HF over ﬁve time periods (T1, 2003–2004; T4. Discussion
The proportion of elderly in the study area population is growing
rapidly, providing a basis for projection of future population structures
in developed countries. We found the following: 1) the age of hospital-
ized patients with HF has increased signiﬁcantly over the last decade in
both sexes; 2) age adjusted incidence over the 10 year study period did
not change in men, but decreased signiﬁcantly by approximately 25% in
women; 3) in-hospitalmortality did not change across the timeperiods;
4) the number and proportion of HF preserved-EF cases tended to
increase during the study period.
In the research region, only six general hospitals have admission
facilities, while other private clinics in the area have outpatient facilities
only and rarely provide clinical care for overt HF patients. Thus patients
with HF who have clinical symptoms are usually transferred for admis-
sion to one of these six hospitals. In addition, to capture patients who
were hospitalized for HF in remote areas outside of the study district,
our registration study was extended to include several teaching hospi-
tals located out of the study area. We are therefore conﬁdent that the
registration process will have captured almost all hospitalized patients
with HF within the area concerned. These ﬁndings of the present
study may therefore be able to clarify the community based incidence
and prevalence rates of acute decompensated HF in our population.
The present study found that the age adjusted incidence of HF in
men did not change signiﬁcantly over the 10 year study period. In con-
trast, the rate in women decreased gradually by 25% over this time. Few
previous reports have described sex speciﬁc temporal trends in the pop-
ulation based incidence of HF. This makes it difﬁcult to compare our re-
search ﬁndings with the results of previous studies from other
populations, as the deﬁnition of HF differs between reports (i.e., the2, 2005–2006; T3, 2007–2008; T4, 2009–2010; T5, 2011–2012). **p for trend b0.01.
Fig. 4. Sex speciﬁc temporal trends in crude and age adjusted prevalence rates of HF over ﬁve time periods (T1, 2003–2004; T2, 2005–2006; T3, 2007–2008; T4, 2009–2010; T5, 2011–
2012).
19M. Honma et al. / IJC Heart & Vasculature 9 (2015) 15–21Framingham deﬁnition [4–7], the Boston criteria [7], the European Soci-
ety of Cardiology deﬁnition [8], and the International Classiﬁcation of
Disease [9]). In addition, categories of HF (i.e., hospitalized patients
only or including outpatients) also differ. However, when the present
data are compared to previous studies for hospitalized HF, the rates
found in this study are lower than those found in other locations such
as North America [19,20] and Scotland [9,21]. Deﬁnitive reasons for
this lower incidence of HF in our population remain unknown, but the
prevalence of coronary heart disease, which is the main burden of HF,
is clearly lower among the Japanese than among North American and
European populations [22]. In accord with the lower incidence of HF
in our population, Ng et al. have reported using national public hospital
andmortality data in Singapore to show that the hospitalization rate for
HF in Chinese was 35% lower than in Malays or Indians [23]. Bahrami
et al. demonstrated in a US multiethnic cohort study that the incidence
of HF in Chinese Americans was the lowest in a comparison among
African Americans, Hispanic, and Whites [24]. In view of these reports,
the lower incidence and prevalence of HF observed in our population
is likely to have been due to ethnic differences speciﬁcally lower inci-
dence of atherosclerotic cardiac disorders. Another possible factor un-
derlying the low incidence of HF may be Japan's relatively affordable
and accessible health care system [25]which allows easy access tomed-
ical facilities before overt HF and hospitalization.
The present study has shown a sex difference in temporal trends in
HF over a recent 10 year period. There are a few population based re-
ports describing sex speciﬁc chronological changes in the incidence of
HF. In the Framingham study, during a recent 50 year period, the rateFig. 5. Sex and age speciﬁc prevalence rate of HF over ﬁve time periods (T1, 2003–2004; T2, 200
b0.01.of HF has not changed signiﬁcantly in men but has fallen by 30% in
women [4]. Conversely, in the Olmsted study, the rate of HF in the
Mayo clinic group did not change in either sex over a recent 30 year pe-
riod [11]. The present study appears to agree with the Framingham
study by ﬁnding that HF rates have remained stable in men while de-
creasing signiﬁcantly by about 25% in women. The reasons for these
sex differences remain unclear on the basis of this research, although
an ofﬁcial report has shown that the prevalence of several cardiovascu-
lar risk factors such as diabetes, obesity, hypertension and smoking are
lower in women than in men [26]. In addition, the prevalence of hyper-
tension in Japanese population has been reported to decrease during the
recent years in all 10-year age groups of women (30–79 years) and
younger men (30 s and 40 s). However, this trend did not occur in
men aged ≥50 years [27]. These sex differences in epidemiological
trends for CV risk factors will reduce the risk of onset of various types
of heart disease and thus contribute to the observed decrease in the in-
cidence and prevalence of HF in women.
The present study also suggests that the number and proportion of
HF preserved-EF increased over the study period. Although the reasons
for this were not clariﬁed, the mean age of HF increased signiﬁcantly in
both sexes over time. The aging progress leads to an increase in the
prevalence of the comorbidities of hypertensive left ventricular hyper-
trophy and diabetes mellitus, both of which are commonly associated
with HF preserved-EF. In addition, several studies have demonstrated
that aging increases diastolic left ventricular elastance and vascular stiff-
ness [28]. Cardiovascular stiffening is most prominent in the population
at risk for HF preserved-EF and is therefore considered a major risk5–2006; T3, 2007–2008; T4, 2009–2010; T5, 2011–2012). *p for trend b0.05, **p for trend
Fig. 6. Sex speciﬁc temporal trends in proportion of patients with HF reduced-EF versusHF preserved-EFwithin incident cohort overﬁve time periods (T1, 2003–2004; T2, 2005–2006; T3,
2007–2008; T4, 2009–2010; T5, 2011–2012).
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and percentage of HF preserved-EFmay therefore be due to the increas-
ing age of HF patients along with general population aging.
The rate of in-hospital mortality did not improve signiﬁcantly across
the study period in either the incident or the prevalent HF cohort.
During the past decade, there have been important advances in the
management of cardiovascular disease, including greater use of vasodi-
lators, renin–angiotensin–aldosterone blockers, and beta-blockers for
improving prognosis of HF. However, limited data exist to showwheth-
er survival rates for real-world HF have changed over time. MacIntyre
et al. reported that the 30 day case fatality rate in hospitalized patients
with HF in Scotland improved 26% in men and 17% in women [29]. Ni
et al. also demonstrated that in-hospital deaths with a primary diagno-
sis of HF in Oregon hospitals decreased [30]. Although these results ap-
pear to vary from our ﬁndings, previous reports concerning temporal
trends for in-hospital prognosis may be inconsistent. In fact, crude and
age adjusted 30 day mortality for hospitalized patients with HF has
been reported to remain steadily high between 1997 and 2007 [31].
Roger et al. have reported that age adjusted 30daymortality did not im-
prove signiﬁcantly in women or elderly persons [6]. These incongruent
estimates could in part come from regional variations in patient popula-
tion, availability of health services, and the selection and deﬁnition of HF
applied. Indeed, the present HF cohort was relatively advanced in age
with the possible presence of comorbidities and preserved-EF, thus HF
in this group may have been refractory to recent standard medical
therapy.
Despite the advantages afforded by our prospective population
based study design using standardHF criteria over a 10 year period, sev-
eral limitationsmust be considered. First, as thiswas an epidemiological
study, detailed echocardiographic parameters for left ventricular
diastolic function could not be obtained and ejection fraction could
not be measured in approximately 10% of patients registered. As a
result, although the proportion of patients who underwent TTE was
approximately 90% and remained stable during the study period, the
analysis of left ventricular function subtype may have some inherent
bias. As the ejection fraction data tended to be lacking more among fe-
male cases (Table 1), numbers of patients with HF preserved-EF may
have been underestimated. Second, the east Japan earthquake and tsu-
nami which occurred in the Iwate prefecture in 2011, thus during the
study period, may have had an impact on the present results. However,
ofﬁcial statistics for the disaster showed that there were only two vic-
tims and no refugees in the present study area (northern Iwate sea
coast and inlands areas) [32]. This suggests that damage caused by the
disaster in the study areaswasmuch less serious. In addition, our previ-
ous study demonstrated that the incidence of HF in the same area was
stable for several months after the disaster [33]. On the basis of thesedata we believe that any bias induced by the disaster in the incidence
of HF regardless of the presence or absence of preserved EF in the
present study area may be small. Third, the present study did not
attempt to determine the etiology of HF as a large proportion of cases
were very elderly andmay thus have had overlapping etiologies (ie, cor-
onary artery and hypertensive heart disease), and been unsuitable for
detailed cardiac examination such as invasive angiography or stress
myocardial perfusion imaging.
In conclusion, although the incidence of HF declined over the recent
decade in our population, especially inwomen, the number and propor-
tion of HF preserved-EF is increasing. These trends suggest a future
prevalence of HF preserved-EF rather than HF reduced-EF in the aging
general population.
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